BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16168712)

  • 1. B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis.
    Liang W; Karabekian Z; Mattapallil M; Xu Q; Viley AM; Caspi R; Scott DW
    Clin Immunol; 2006 Jan; 118(1):35-41. PubMed ID: 16168712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
    Singh VK; Anand R; Sharma K; Agarwal SS
    Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic suppression of experimental autoimmune uveitis].
    Thurau SR; Caspi RR; Chan CC; Weiner HL; Nussenblatt RB
    Fortschr Ophthalmol; 1991; 88(4):404-7. PubMed ID: 1838532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
    Eto K; Suzuki S; Singh VK; Shinohara T
    Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction].
    Zheng YZ; Yuan LL; Lin JY; Li HQ
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1118-22. PubMed ID: 17415971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
    McPherson SW; Roberts JP; Gregerson DS
    Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
    Kohno H; Sakai T; Saito S; Okano K; Kitahara K
    Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
    Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis.
    McPherson SW; Roberts JP; Gregerson DS
    J Immunol; 1999 Oct; 163(8):4269-76. PubMed ID: 10510365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune uveitis in the athymic nude rat.
    Salinas-Carmona MC; Nussenblatt RB; Gery I
    Eur J Immunol; 1982 Jun; 12(6):480-4. PubMed ID: 6981513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine-induced alterations of humoral response in experimental autoimmune uveitis.
    Chan CC; Palestine AG; Nussenblatt RB
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):867-70. PubMed ID: 6234255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
    Sunil S; Eto K; Singh VK; Shinohara T
    Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporine on T-cell subsets in experimental autoimmune uveitis.
    Nussenblatt RB; Scher I
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):10-4. PubMed ID: 3871429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids enhance S-antigen expression in nonretinal ocular tissues of rats with experimental autoimmune uveitis.
    Li Q; Abe T; Kikuchi T; Nussenblatt RB; Shinohara T; Chan CC
    Exp Mol Pathol; 1994 Feb; 60(1):27-38. PubMed ID: 8162968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein.
    Roberts AJ; Kasp E; Stanford M; Dumonde DC; Banga JP
    Eur J Immunol; 1992 Apr; 22(4):951-6. PubMed ID: 1551407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rodent models of experimental autoimmune uveitis.
    Agarwal RK; Caspi RR
    Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of non-major histocompatibility antigen complex gene in experimental autoimmune uveitis.
    Yoshikawa K; Hirose S; Sasamoto Y; Kotake S; Matsuda H
    Jpn J Ophthalmol; 1995; 39(4):347-52. PubMed ID: 8926641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold.
    Lei TC; Su Y; Scott DW
    Cell Immunol; 2005 May; 235(1):12-20. PubMed ID: 16098495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological aspects of spontaneous uveitis and retinopathy in HLA-A29 transgenic mice and in animal models of retinal autoimmunity: relevance to human pathologies.
    de Kozak Y; Camelo S; Pla M
    Ophthalmic Res; 2008; 40(3-4):175-80. PubMed ID: 18421235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for immunological tolerance: using 'transgenic' B cells to treat inhibitor formation.
    Scott DW
    Haemophilia; 2010 May; 16(102):89-94. PubMed ID: 20536991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.